WOMAN 1:
Have hepatitis C but haven’t taken care of it yet? Maybe you’ve been waiting for a sign. Well here it is.
C is Cover the basics of Hep C. Over 2 million people have Hep C, a virus that attacks your liver and spreads mainly through blood-to-blood contact. Your liver keeps you healthy by sorting out good nutrients from bad toxins. If left untreated, Hep C can damage your liver until it can’t do its job. Hep C can be spread through the sharing of needles, dirty tattoo equipment, or sex with a person who has Hep C.
TEXT ON-SCREEN:
C Cover the Basics
TEXT ON-SCREEN:
These are common ways of transmission. Hep C can also be spread by other means, such as from mother to unborn child.
WOMAN 1:
As long as you have Hep C, you can spread it to others.
MAN 1:
U is Understand the symptoms of Hep C which may include upset stomach, feeling tired, and more. Thing is, you can have Hep C for years without showing any symptoms. This means a lot of people don’t even know they have Hep C. Or if they do know they have it, they put off treatment. This can cause more problems later.
TEXT ON-SCREEN:
U Understand the Symptoms
WOMAN 2:
R is Real talk with your healthcare provider. Have an honest discussion with them to get the right treatment for you. Tell them if you have other conditions, take other medications, or have struggled with addiction.
TEXT ON-SCREEN:
R Real Talk
TEXT ON-SCREEN:
Other conditions?
Other medications?
Addiction?
MAN 2:
E is EPCLUSA. A treatment that can work for whatever type of Hep C you have.
TEXT ON-SCREEN:
E Epclusa
TEXT ON-SCREEN:
EPCLUSA is a prescription medicine used to treat adults with chronic Hep C genotype 1-6 with or without cirrhosis (compensated).
MAN 2:
Ask your healthcare provider if EPCLUSA could be your kind of cure.
TEXT ON-SCREEN:
Cure means the Hep C virus is not detected in the blood when measured 3 months after treatment is completed.
MAN 2:
It has a 98% overall cure rate with just one pill,once a day taken with or without food for 12 weeks.
TEXT ON-SCREEN:
98% OVERALL CURE RATE
TEXT ON-SCREEN:
1 PILL, ONCE A DAY, WITH OR WITHOUT FOOD
TEXT ON-SCREEN:
In studies of genotype 1-6 patients without cirrhosis or with compensated cirrhosis.
MAN 2:
Before starting EPCLUSA, your doctor will test if you have had hepatitis B, which may flare up or could cause serious liver problems during and after treatment.
TEXT ON-SCREEN:
If you have ever had hepatitis B, it may flare up or could cause serious or life-threatening liver problems.
MAN 2:
After completing treatment, you will get tested to confirm that you’ve been cured.
Being cured of Hep C doesn’t mean you can’t get it again. So, don’t put yourself at risk of getting re-infected.
WOMAN 1:
If you’ve been waiting for a sign, now’s the time to C-U-R-E. That’s, cover the basics of Hep C.
TEXT ON-SCREEN:
C.U.R.E.
TEXT ON-SCREEN:
Cure means the Hep C virus is not detected in the blood when measured 3 months after treatment is completed.
MAN 1:
Understand the symptoms.
WOMAN 2:
Real talk with your healthcare provider.
MAN 2:
And EPCLUSA could be your kind of cure.
ANNOUNCER 1:
Ask you healthcare provider about EPCLUSA today.
ANNOUNCER 2:
What is EPCLUSA?
EPCLUSA is a prescription medicine used to treat adults with chronic hepatitis C (Hep C) genotype 1- 6 infection with or without cirrhosis (compensated).
What is the most important information I should know about EPCLUSA?
EPCLUSA can cause serious side effects, including:
Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and
death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.
What should I tell my healthcare provider before taking EPCLUSA?
Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection or liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if
EPCLUSA will harm your unborn baby or pass into your breast milk.
Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.
What are the possible side effects of EPCLUSA?
Serious side effects may also include slow heart rate (bradycardia). EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.
The most common side effects of EPCLUSA include headache and tiredness.
Tell your healthcare provider if you have any side effect that bothers you or does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
TEXT ON-SCREEN:
What is EPCLUSA?
EPCLUSA is a prescription medicine used to treat adults with chronic hepatitis C (Hep C) genotype 1- 6 infection with or without cirrhosis (compensated).
What is the most important information I should know about EPCLUSA?
EPCLUSA can cause serious side effects, including:
Hepatitis B virus reactivation: Before starting EPCLUSA treatment, your healthcare provider will do blood tests to check for hepatitis B infection. If you have ever had hepatitis B, the hepatitis B virus could become active again during and after treatment with EPCLUSA. This may cause serious liver problems including liver failure and death. If you are at risk, your healthcare provider will monitor you during and after taking EPCLUSA.
What should I tell my healthcare provider before taking EPCLUSA?
• Tell your healthcare provider about all of your medical conditions, including if you have ever had hepatitis B infection or liver problems other than hepatitis C infection, or a liver transplant; if you have kidney problems or are on dialysis; if you have HIV; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if EPCLUSA will harm your unborn baby or pass into your breast milk.
• Tell your healthcare provider and pharmacist about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPCLUSA and certain other medicines may affect each other, or may cause side effects.
What are the possible side effects of EPCLUSA?
Serious side effects may also include slow heart rate (bradycardia). EPCLUSA, when taken with amiodarone (Cordarone®, Nexterone®, Pacerone®), a medicine used to treat certain heart problems, may cause slow heart rate. In some cases slow heart rate has led to death or the need for a pacemaker when amiodarone is taken with medicines containing sofosbuvir. Get medical help right away if you take amiodarone with EPCLUSA and get any of the following symptoms: fainting or near-fainting, dizziness or lightheadedness, not feeling well, weakness, extreme tiredness, shortness of breath, chest pains, confusion, or memory problems.
The most common side effects of EPCLUSA include headache and tiredness.
Tell your healthcare provider if you have any side effect that bothers you or does not go away.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Important Facts about EPCLUSA including Important Warning on EPCLUSA.com.
EPCLUSA, the EPCLUSA logo, GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks referenced herein are the property of their respective owners.
©2020 Gilead Sciences, Inc. All rights reserved. EPCC0533 09/20